Highly Stable PEGylated Poly(lactic-co-glycolic acid) (PLGA) Nanoparticles for the Effective Delivery of Docetaxel in Prostate Cancers

In the present study, a highly stable luteinizing-hormone-releasing hormone (LHRH)-conjugated PEGylated poly(lactic-co-glycolic acid) (PLGA) nanoparticles were developed for the successful treatment of prostate cancers. We have demonstrated that a unique combination of targeted drug delivery and con...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Long-Bin, Zeng, Sha, Zhao, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Nano Express
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916070/
https://www.ncbi.nlm.nih.gov/pubmed/27325521
http://dx.doi.org/10.1186/s11671-016-1509-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916070/
https://www.ncbi.nlm.nih.gov/pubmed/27325521
http://dx.doi.org/10.1186/s11671-016-1509-3

Ejemplares similares